Dana-Farber Cancer Institute
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Dana-Farber Cancer Institute
May 1, 2024, 16:28 |
Career
Toni Choueiri: The Dana-Farber Lank Center for Genitourinary Oncology is hiring again
Toni Choueiri shared on X: “Well, the Dana-Farber Lank Center for Genitourinary Oncology is hiring…
May 1, 2024, 04:54 |
Blog
Howard McLeod: Preemptive DPYD Testing Program for patients planned for a systemic Fluoropyrimidine
Howard McLeod, Central Director, Founder and Advisor at Precision Medicine, shared on LinkedIn: “The USA…
May 1, 2024, 01:17 |
Blog
Jun Qi: Our article on EP300/CBP bromodomain inhibition in Group 3 medulloblastoma is now published
Jun Qi, Assistant Professor of Medicine at Dana-Farber Cancer Institute, shared a post on LinkedIn:…
Apr 30, 2024, 12:22 |
Insight
Harold Burstein: ER-low tumors will require chemotherapy and endocrine therapy
Harold Burstein, Breast Cancer Specialist and Professor at Dana Farber Cancer Institute, shared a post…
Apr 29, 2024, 15:12 |
Blog
Damon Runyon Cancer Research Foundation 2024 Quantitative Biology Fellow - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Congratulations to Dana-Farber's Ahmed Roman, PhD, who…
Apr 28, 2024, 11:48 |
Drugs
Tovorafenib has now been approved for young patients with relapsed or progressive pediatric low-grade glioma - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute recently shared on LinkedIn: "For more than a decade, a collaborative team…
Apr 28, 2024, 11:19 |
Blog
Paolo Tarantino: Truly groundbreaking work that turned a failed chemotherapy in one of the most active anticancer drugs ever developed
Paolo Tarantino shared a post by Florian Muller, Co-Head of Biology at Powder Gate Discovery, on…
Apr 27, 2024, 14:14 |
Blog
Registration is open for NANETS. Regional NET Education Program in Providence - Yale Cancer Center
Pamela Kunz shared a post by Yale Cancer Center, on X: "Please join us for this great…
Apr 26, 2024, 17:44 |
Drugs
Paolo Tarantino: The agnostic potential of Antibody Drug Conjugates with Roberto Carmagnani Pestana, MD is among the most cited of 2022-2023 on CA - A Cancer Journal for Clinicians
Apr 26, 2024, 10:00 |
Insight
Biagio Ricciuti: Our work on long-term outcomes to PD-1 monotherapy by increasing PD-L1 levels in NSCLC is out in JTO and JTO CRR
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter: ''Our work on long-term…
2
3
4
5
6
All:
150
Posts:
31 - 40
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube